Omnimmune Holdings (Omnimmune Holdings) Change In Payables And Accrued Expense : $0.97 Mil (TTM As of Sep. 2010)

View and export this data going back to 2007. Start your Free Trial

What is Omnimmune Holdings Change In Payables And Accrued Expense?

Omnimmune Holdings's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2010 was $0.23 Mil. It means Omnimmune Holdings's Accounts Payable & Accrued Expense increased by $0.23 Mil from Jun. 2010 to Sep. 2010 .

Omnimmune Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2009 was $1.43 Mil. It means Omnimmune Holdings's Accounts Payable & Accrued Expense increased by $1.43 Mil from May. 2008 to Dec. 2009 .

Omnimmune Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Omnimmune Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnimmune Holdings Change In Payables And Accrued Expense Chart

Omnimmune Holdings Annual Data

Trend

May07

May08

Dec09

Change In Payables And Accrued Expense

1.43

Omnimmune Holdings Quarterly Data
	May07	Aug07	Nov07	Feb08	May08	Aug08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10
Change In Payables And Accrued Expense	Get a 7-Day Free Trial									0.41	0.37	0.11	0.26	0.23

Omnimmune Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.97 Mil.

Omnimmune Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Omnimmune Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Omnimmune Holdings (Omnimmune Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Omnimmune Holdings Inc (GREY:OMMH) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4600 Post Oak Place, Suite 352, Houston, TX, USA, 77027

Website

Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Omnimmune Holdings (Omnimmune Holdings) Headlines

No Headlines